Activation of human T-cell leukemia virus type 1 Tax gene expression in chronically infected T cells

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 6264-6270

  Lin, Hsin Ching ^a,b   Dezzutti, Charlene S ^c   Lal, Renu B ^c   Rabson, Arnold B ^a,b,d,e  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e CABM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; TAX PROTEIN; VIRUS RNA;

ARTICLE; GENE ACTIVATION; GENE EXPRESSION; HUMAN T CELL LEUKEMIA VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION;

EID: 0031801099     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.6264-6270.1998     Document Type: Article

References (65)

1. Akagi, T., H. Ono, H. Nyunoya, and K. Shimotohno. 1997. Characterization of peripheral blood T-lymphocytes transduced with HTLV-1 Tax mutants with different trans-activating phenotype. Oncogene 14:2071-2078.
2. Andrews, J. M., G. C. Newbound, M. Oglesbee, J. N. Brady, and M. D. Lairmore. 1997. The cellular stress response enhances human T-cell lymphotropic virus type 1 basal gene expression through the core promoter region of the long terminal repeat. J. Virol. 71:741-745.
3. Andrews, J. M., M. J. Oglesbee, A. V. Trevino, D. J. Guyot, G. C. Newbound, and M. D. Lairmore. 1995. Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response. Virology 208:816-820.
4. Baier-Bitterlich, G., J. Rappaport, G. Baier, D. Looney, and F. Wong-Staal. 1994. Transcellular activation of the HTLV promoter by human hematopoietic cells. Oncogene 9:319-322.
5. Baranger, A. M., C. R. Palmer, M. K. Hamm, H. A. Glebler, A. Brauweiler, J. K. Nyborg, and A. Schepartz. 1995. Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature 376: 606-608.
6. Bednarik, D. P., and T. M. Folks. 1992. Mechanisms of HIV-1 latency. AIDS 6:3-16.
7. Bosselut, R., J. F. Duvall, A. Gegonne, M. Bailly, A. Hemar, J. Brady, and J. Ghysdael. 1990. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-I. EMBO J. 9:3137-3144.
8. Bosselut, R., F. Lim, P. C. Romand, J. Frampton, J. Brady, and J. Ghysdael. 1992. Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. Virology 186:764-769.
9. Brady, J., K.-T. Jeang, J. Duvall, and G. Khoury. 1987. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J. Virol. 61:2175-2181.
10. Caron, C., R. Rousset, C. Beraud, V. Moncollin, J. M. Egly, and P. Jalinot. 1993. Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. EMBO J. 12:4269-4278.
11. Cavrois, M., S. Wain-Hobson, A. Gessain, Y. Plumelle, and E. Wattel. 1996. Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type 1-positive cells. Blood 88:4646-4650.
12. Cho, I., M. Sugimoto, S. Mita, M. Tokunaga, F. Imamura, and M. Ando. 1995. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis. Am. J. Trop. Med. Hyg. 53:412-418.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
14. Ciminale, V., G. N. Pavlakis, D. Derse, C. P. Cunningham, and B. K. Felber. 1992. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J. Virol. 66:1737-1745.
15. Clark, N. M., M. J. Smith, J. M. Hilfinger, and D. M. Markovitz. 1993. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J. Virol. 67:5522-5528.
16. Clemens, K. E., G. Piras, M. F. Radonovich, K. S. Choi, J. F. Duvall, J. DeJong, R. Roeder, and J. N. Brady. 1996. Interaction of the human T-cell lymphotropic virus type 1 Tax transactivator with transcription factor IIA. Mol. Cell. Biol. 16:4656-4664.
17. Dezzutti, C. S., D. L. Rudolph, C. R. Roberts, and R. B. Lal. 1993. Characterization of human T-lymphotropic virus type I-and II-infected T cell lines: antigenic, phenotypic, and genotypic analysis. Virus Res. 29:59-70.
18. Dorsett, D. L., I. Keshet, and E. Winocour. 1983. Quantitation of a simian virus 40 nonhomologous recombination pathway. J. Virol. 48:218-228.
19. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type 1 infection. Blood 86:3619-3639.
20. Gazdar, A. F., D. N. Carney, P. A. Bunn, E. K. Russell, E. S. Jaffe, G. P. Schechter, and J. G. Guccion. 1980. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 55:409-417.
21. Gazzolo, L., and M. Duc Dodon. 1987. Direct activation of resting lymphocytes by human T-lymphotropic virus type I. Nature 326:714-717.
22. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de Thé. 1985. Antibodies to the human T lymphotropic virus type 1 in patients with tropical spastic paraparesis. Lancet ii:407-410.
23. Gessain, A., F. Saal, O. Gout, M.-T. Daniel, G. Flandrin, G. de Thé, and F. Sigaux. 1990. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 75:428-433.
24. 1 and Ets1. J. Virol. 67:7307-7316.
25. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
26. Grassmann, R., C. Dengler, I. Muller-Fleckenstein, B. Fleckenstein, K. McGuire, M. C. Dokhelar, J. G. Sodroski, and W. A. Haseltine. 1989. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type 1 X-region genes transduced by a herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA 86:3351-3355.
27. Imagawa, M., R. Chiu, and M. Karin. 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathway: protein kinase C and cAMP. Cell 51:251-260.
28. x-responsive 21-base-pair sequence. J. Virol. 62:4499-4509.
29. Jeang, K.-T., R. Chiu, E. Santos, and S. J. Kim. 1991. Induction of the HTLV-1 LTR by Jun occurs through the Tax-responsive 21-bp elements. Virology 181:218-227.
30. Kira, J.-i., Y. Koyanagi, T. Yamada, Y. Itoyama, I. Goto, N. Yamamoto, H. Sasaki, and Y. Sakaki. 1991. Increased HTLV-I proviral DNA in HTLV-1-associated myelopathy: a quantitative polymerase chain reaction study. Ann. Neurol. 29:194-201.
31. Kwok, R. P., M. E. Laurance, J. R. Lundblad, P. S. Goldman, H. Shin, L. M. Connor, S. J. Marriott, and R. H. Goodman. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642-646.
32. Lin, H.-C., M. Bodkin, R. B. Lal, and A. B. Rabson. 1995. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 Tax response elements in the long terminal repeat. J. Virol. 69:7216-7225.
33. 1 with a responsive element in the viral long terminal repeat. Mol. Cell. Biol. 10:4192-4201.
34. Mathis, D. J., P. Oudet, B. Wasylyk, and P. Chambon. 1978. Effect of histone acetylation on structure and in vitro transcription of chromatin. Nucleic Acids Res. 5:3523-3547.
35. McKendall, R. R., J. Oas, and M. D. Lairmore. 1991. HTLV-1-associated myelopathy endemic in Texas-born residents and isolation of virus from CSF cells. Neurology 41:831-836.
36. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
37. Muchardt, C., J. S. Seeler, A. Nirula, S. Gong, and R. Gaynor. 1992. Transcription factor AP-2 activates gene expression of HTLV-1. EMBO J. 11: 2573-2581.
38. Nerenberg, M., S. H. Hinrichs, R. K. Reynolds, G. Khoury, and G. Jay. 1987. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237:1324-1329.
39. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
40. Ohshima, K., K. Hashimoto, S. Izumo, J. Suzumiya, and M. Kikuchi. 1996. Detection of human T lymphotropic virus type I (HTLV-I) DNA and mRNA in individual cells by polymerase chain reaction (PCR), in situ hybridization (ISH), and reverse transcription (RT)-PCR ISH. Hematol. Oncol. 14:91-100.
41. Osame, M., K. Usuku, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and H. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet. i:1031-1032.
42. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-335.
43. Paskalis, H., B. K. Felber, and G. N. Pavlakis. 1986. cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Prof. Natl. Acad. Sci. USA 83: 6558-6562.
44. Perini, G., S. Wagner, and M. R. Green. 1995. Recognition of bZIP proteins by the human T-cell leukemia virus transactivator Tax. Nature 376:602-605.
45. Poiesz, B. F., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from freshly cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
46. Rabson, A. B., Y. Hamagishi, P. E. Steele, M. Tykocinski, and M. A. Martin. 1985. Characterization of human endogenous retroviral envelope RNA transcripts. J. Virol. 56:176-182.
47. Radonovich, M., and K.-T. Jeang. 1989. Activation of the human T-cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate and by Tax (p40x) occurs through similar but functionally distinct target sequences. J. Virol. 63:2987-2994.
48. Richardson, J. H., P. Hollsberg, A. Windhagen, L. A. Child, D. A. Hafler, and A. M. L. Lever. 1997. Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type 1. Blood 89:3303-3314.
49. Riggs, M. G., R. G. Whitaker, J. R. Neumann, and V. M. Ingram. 1977. n-Butyrate causes histone modification in HeLa and Friend erythroleukemia cells. Nature 268:462-464.
50. Sealy, L., and R. Chalkley. 1978. The effect of sodium butyrate on histone modification. Cell 14:115-121.
51. Seeler, J.-S., C. Muchardt, M. Podar, and R. Gaynor. 1993. Regulatory elements involved in Tax-mediated transactivation of the HTLV-I LTR. Virology 196:442-450.
52. Setoyama, M., T. Fujiyoshi, S. Mizoguchi, Y. Katahira, S. Yashiki, M. Tara, T. Kanzaki, and S. Sonoda. 1994. HTLV-I messenger RNA is expressed in vivo in adult T-cell leukemia/lymphoma patients: an in situ hybridization study. Int. J. Cancer 57:760-764.
53. Setoyama, M., Y. Katahira, T. Hamada, M. Tashiro, S. Yashiki, Y. Tanaka, H. Tozawa, and S. Sonoda. 1992. Expression of human T-cell lymphotropic virus type 1 gene products in the short-term cultured skin tissues of an adult T-cell leukemia/lymphoma patient with cutaneous manifestations. J. Dermatol. 19:133-139.
54. Shimotohno, K., M. Takano, T. Teruuchi, and M. Miwa. 1986. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc. Natl. Acad. Sci. USA 83:8112-8116.
55. Smith, M. R., and W. C. Greene. 1941. Molecular biology of the type 1 human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. J. Clin. Invest. 87:761-766.
56. Sodroski, J. G., C. A. Rosen, and W. A. Haseltine. 1984. Transacting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381-385.
57. Suzuki, T., J. I. Fujisawa, M. Toita, and M. Yoshida. 1993. The trans-activator Tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl. Acad. Sci. USA 90:610-614.
58. Uchiyama, T. 1997. Human T cell leukemia virus type 1 (HTLV-1) and human diseases. Annu. Rev. Immunol. 15:15-37.
59. Wattel, E., M. Cavrois, A. Gessain, and S. Wain-Hobson. 1996. Clonal expansion of infected cells: a way of life for HTLV-1. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:S92-S99.
60. Wattel, E., J.-P. Vartanian, C. Pannetier, and S. Wain-Hobson. 1995. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69:2863-2868.
61. Weiss, A., and J. D. Stobo. 1984. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med. 160:1284-1299.
62. Wucherpfenning, K. W., P. Hollsgerg, J. H. Richard, D. Benjamin, and D. A. Hafler. 1992. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc. Natl. Acad. Sci. USA 89:2110-2114.
63. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implications in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
64. Yoshida, M., T. Suzuki, J. Fujisawa, and H. Hirai. 1995. HTLV-1 oncoprotein Tax and cellular transcription factors. Curr. Top. Microbiol. Immunol. 193:79-89.
65. Zhao, L.-J., and C.-Z. Giam. 1991. Interaction of the human T-cell lymphotropic virus type I (HTLV-1) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc. Natl. Acad. Sci. USA 88:11445-11449.